Ohad Hammer, Partner at Pontifax Venture Capital
Ohad has been a biotech analyst at Pontifax for 8 years. He is involved in identifying and evaluating new investment opportunities. Ohad focuses on early-stage projects and oversees scouting, due diligence, and company formation. He also supports development and business development activities [AD3] within Pontifax’s early-stage portfolio companies. Ohad earned his MS in biology from Tel Aviv University in Israel, and writes about small- and mid-cap biotech stocks on his blog, www.orf-blog.com.